Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancer.

We have evaluated the prognostic value of tumour-associated trypsin inhibitor (TATI) in stage III or IV ovarian cancer. Tumour-associated trypsin inhibitor (TATI) and CA 125 were determined in serum samples from 66 patients taken before primary surgery. TATI was elevated (> 22 micrograms l-1) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Venesmaa, P., Lehtovirta, P., Stenman, U. H., Leminen, A., Forss, M., Ylikorkala, O.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033663/
https://www.ncbi.nlm.nih.gov/pubmed/7981075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033663/
https://www.ncbi.nlm.nih.gov/pubmed/7981075

Ejemplares similares